TENAX THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount
TENAX THERAPEUTICS, INC. (TENX) reported Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount of -$54.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherReconcilingItems · last filed 2026-03-10
- TENAX THERAPEUTICS, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2024 was -$54.00K.
- TENAX THERAPEUTICS, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2023 was -$7.00K, a 179.10% decline from fiscal 2022.
- TENAX THERAPEUTICS, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2022 was $8.85K.
- TENAX THERAPEUTICS, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2021 was -$73.00.
| Period end | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount 12 month | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount 12 month as first filed |
|---|---|---|
| 2024-12-31 | -$54.00K 10-K · filed 2026-03-10 | |
| 2023-12-31 | -$7.00K 10-K · filed 2025-03-25 | -$7.15K 10-K · filed 2024-03-28 |
| 2022-12-31 | $8.85K 10-K · filed 2024-03-28 | |
| 2021-12-31 | -$73.00 10-K · filed 2023-03-31 | |
| 2020-12-31 | -$56.64K 10-K · filed 2022-03-29 | |
| 2019-12-31 | -$17.04K 10-K/A · filed 2021-04-16 | |
| 2018-12-31 | -$31.81K 10-K · filed 2020-03-30 | |
| 2014-04-30 | $53.62K 10-K · filed 2014-07-29 | |
| 2013-04-30 | $132.81K 10-K · filed 2014-07-29 | |
| 2012-04-30 | -$95.00K 10-K · filed 2013-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |